Communication from the Executive Office of Health and Human Services (pursuant to item 4000-0300 of Chapter 28 of the Acts of 2023) submitting its MassHealth pharmaceutical utilization report

This document is a formal report submitted by the Massachusetts Executive Office of Health and Human Services to state legislative committees regarding MassHealth pharmaceutical spending. It details financial data for fiscal years 2023 and 2024, including total drug expenditures, rebate amounts collected from manufacturers, and the federal funding share received for these costs. The report highlights that MassHealth spent $2.7 billion on drugs in FY23 and estimates $2.9 billion for FY24, while securing approximately $1.66 billion and $1.76 billion in rebates respectively. It also notes that adding new drugs to the coverage list has increased projected spending due to higher utilization of high-cost medications.